AAAAAA

   
Results: 1-3 |
Results: 3
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine,BCH-4556) and AraC against leukemic human tumor xenografts expressing highor low cytidine deaminase activity
Authors: Gourdeau, H Bibeau, L Ouellet, F Custeau, D Bernier, L Bowlin, T
Citation: H. Gourdeau et al., Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine,BCH-4556) and AraC against leukemic human tumor xenografts expressing highor low cytidine deaminase activity, CANC CHEMOT, 47(3), 2001, pp. 236-240
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines
Authors: Gourdeau, H Clarke, ML Ouellet, F Mowles, D Selner, M Richard, A Lee, N Mackey, JR Young, JD Jolivet, J Lafreniere, RG Cass, CE
Citation: H. Gourdeau et al., Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines, CANCER RES, 61(19), 2001, pp. 7217-7224
Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine
Authors: de Muys, JM Gourdeau, H Nguyen-Ba, N Taylor, DL Ahmed, PS Mansour, T Locas, C Richard, N Wainberg, MA Rando, RF
Citation: Jm. De Muys et al., Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine, ANTIM AG CH, 43(8), 1999, pp. 1835-1844
Risultati: 1-3 |